Lamb D J, Bullock D W, Hoyte R M, Hochberg R B
Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030.
Endocrinology. 1988 May;122(5):1923-32. doi: 10.1210/endo-122-5-1923.
We have synthesized 16 alpha-iodo-4,9-estradien-17 beta-ol-3-one [delta 9-16 alpha-iodo-19-nortestosterone (delta 9-INT)] labeled with 125I (delta 9-[16 alpha-125I]INT) to provide a new gamma-emitting photoaffinity ligand for the progesterone receptor that has many advantages over the currently available [3H]R5020. We have characterized the interaction of delta 9-[16 alpha-125I]INT with the rabbit uterine progesterone receptor and have demonstrated the usefulness of this compound for studies of receptor structure. The binding of 2 nM [3H]progesterone to receptor in rabbit uterine cytosol was specifically competed for by 19-nortestosterone, 16 alpha-iodo-19-nortestosterone, and delta 9-INT. Scatchard analysis demonstrated that delta 9-[16 alpha-125I]INT and [3H]progesterone estimated the same number of binding sites in rabbit uterine cytosol, with a Kd for delta 9-[16 alpha-125I]INT of about 2.7 nM. The binding of delta 9-[16 alpha-125I]INT was inhibited by both progesterone and R5020, whereas testosterone, estradiol, and 5 alpha-dihydrotestosterone were ineffective. In cytosol, delta 9-[16 alpha-125I]INT covalently labeled the same mol wt receptor forms as [3H]R5020. Although the efficiency of cross-linking was similar for [3H]R5020 (3%) and delta 9-[16 alpha-125I]INT (4%), the radioactivity was 10-fold greater due to the higher specific activity of delta 9-[16 alpha-125I]INT and the lack of sample quench. The use of delta 9-[16 alpha-125I]INT greatly increases the sensitivity and efficiency of the photoaffinity labeling technique; it will provide a valuable tool for further studies of the progesterone receptor, allowing the detection of receptor in dilute cytosol after gel electrophoresis under denaturing conditions.
我们已合成了用¹²⁵I标记的16α-碘-4,9-雌二烯-17β-醇-3-酮[δ⁹-16α-碘-19-去甲睾酮(δ⁹-INT)][δ⁹-[16α-¹²⁵I]INT],以提供一种新的用于孕酮受体的发射γ射线的光亲和配体,它比目前可用的[³H]R5020有许多优点。我们已对δ⁹-[16α-¹²⁵I]INT与兔子宫孕酮受体的相互作用进行了表征,并证明了该化合物在受体结构研究中的有用性。2 nM[³H]孕酮与兔子宫胞质溶胶中受体的结合被19-去甲睾酮、16α-碘-19-去甲睾酮和δ⁹-INT特异性竞争。Scatchard分析表明,δ⁹-[16α-¹²⁵I]INT和[³H]孕酮在兔子宫胞质溶胶中估计的结合位点数相同,δ⁹-[16α-¹²⁵I]INT的Kd约为2.7 nM。δ⁹-[16α-¹²⁵I]INT的结合受到孕酮和R5020的抑制,而睾酮、雌二醇和5α-二氢睾酮则无效。在胞质溶胶中,δ⁹-[16α-¹²⁵I]INT与[³H]R5020共价标记相同分子量的受体形式。虽然[³H]R5020(3%)和δ⁹-[16α-¹²⁵I]INT(4%)的交联效率相似,但由于δ⁹-[16α-¹²⁵I]INT的比活性较高且不存在样品淬灭,放射性高10倍。使用δ⁹-[16α-¹²⁵I]INT大大提高了光亲和标记技术的灵敏度和效率;它将为孕酮受体的进一步研究提供有价值的工具,允许在变性条件下进行凝胶电泳后在稀释的胞质溶胶中检测受体。